ARCHIVES

Clinical Biomarker Discovery Initiative would speed progress in early detection and measurement of response to therapy, Leland Hartwell tells NCI.

This article is from The Cancer Letter archive.

Vol. 30 No. 43 | November 12, 2004

Download PDF Visit The Full Archive

Related Articles

Reviewers Found For Chronobiolgy

June 30, 1989

Phase III Trial Data: Lenvatinib Extends PFS by Over 14 Months

June 27, 2014

Medicare Should Pay Routine Care For Patients in Trials: IOM.

January 7, 2000

Tempero, Johnson To Lead ASCO

March 28, 2003

NCI-DOD Agreement Could Be Model For Similar Project With HCFA, Lee Says

March 8, 1996

Five-Fold Increase in Chordoma Risk Linked to Common Gene Variant

October 26, 2012